Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A combination topical analgesic for **temporary relief of minor aches and pains in muscles and joints**, typically used in the form of creams, gels, or patches. - **Menthol** acts as a counterirritant, producing a cooling sensation by activating TRPM8 receptors and reducing pain perception. - **Camphor** also acts as a counterirritant, producing both cooling and warming sensations that distract from pain, as well as mild local anesthetic effects via TRPV1 and other channels. - **Capsaicin** (from capsicum) acts via sustained activation and subsequent desensitization of the TRPV1 (vanilloid) receptor, resulting in depletion of substance P, a neuropeptide involved in pain transmission, which leads to reduced pain signal transmission[3][5]. The combination is commonly available over the counter for musculoskeletal pain associated with arthritis, backache, sprains, and strains.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on menthol + camphor + capsaicin.